Waymo expanded robotaxi service, raised 16 billion dollars, served over 20 million rides, but faces regulatory delays stalling its Washington, DC launch.
FDA slows down on drug reviews, approvals amid Trump admin chaos
FDA drug approvals slowed, review delays and rejections increased, manufacturing inspection issues rose, and a government shutdown prevents accepting new drug submissions.
Can AI companies turn brainrot into revenue? | TechCrunch
Startups face existential risk from the U.S. government shutdown due to delayed permits, visas, or regulatory approvals, while AI companies struggle with sustainable business models.